Dr. Reddy to launch an anti-blood clot drug in Canada

Nov 6, 2013 09:25 IST

Dr. Reddy's Laboratories is set to take its complex generic drug named Fondaparinux sodium injection to Canada as well as two other emerging markets. The Alchemia Ltd. statement says that the Australian Pharmaceutical company that has tie-up for marketing with the city-based drug maker, Dr. Reddy's is expected to file for approval in up to four additional territories in 2014.

Dr. Reddy's Laboratories
Dr. Reddy’s began as an API manufacturer in 1984, producing high-quality APIs is the first Indian and later, the international markets. In 1987, we it started formulations operations and after becoming a force to reckon with in the Indian formulations market, it went international in 1991.

Is this article important for exams ? Yes46 People Agreed

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK